TY - JOUR
T1 - A drug-drug interaction knowledge assessment instrument for health professional students
T2 - A Rasch analysis of validity evidence
AU - Warholak, Terri L.
AU - Menke, J. Michael
AU - Hines, Lisa E.
AU - Murphy, John E.
AU - Reel, Sally
AU - Malone, Daniel C.
N1 - Funding Information:
Funding/Support: This project was funded under grant number U18 HS017001-01 (PI: R. Woosley) from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services . The opinions expressed in this document are those of the authors and do not reflect the official position of AHRQ or the U.S. Department of Health and Human Services.
PY - 2011/3
Y1 - 2011/3
N2 - Background: It is essential that current and future health professionals be able to evaluate for possible clinically significant drug-drug interactions (DDIs) and when detected, determine appropriate management strategies to prevent patient harm. Objective: Assess the validity of a DDI knowledge assessment instrument in a health professional student population. Methods: This study recruited health professional students (medical, nurse practitioner, and pharmacy) beginning experiential training at the University of Arizona. Students were given a knowledge assessment instrument that included 15 medication pairings selected on the basis of clinical importance and were asked to select the most appropriate DDI management strategy for each pair by selecting " avoid combination," " usually avoid combination," " take precautions," or " no special precautions." Data were analyzed in 2 ways because of the subjective nature of classifying DDIs into specific management categories. In the first analysis, respondents were given credit for a correct item only if they selected the management strategy deemed appropriate (management strategy analysis). In another analysis, students were given credit for an item only if they correctly identified specific DDIs (DDI recognition analysis). Rasch analysis was used to assess the validity of the knowledge instrument. Results: A total of 165 of the 226 eligible health professional students completed the DDI knowledge assessment (73% response rate). The mean score for management strategy analysis was 3.82 out of 15, whereas DDI recognition analysis produced a higher average (mean. =6.55). Good reliability was demonstrated in both strategies, and no ceiling or floor effects were observed. Some construct underrepresentation occurred with both scoring strategies, and some mistargeting was identified when analyzing the management strategy. Conclusions: Although improvements in construct representation may be beneficial, the instrument used demonstrated good reliability and validity and could be used by educators to assess and improve DDI knowledge. The ability of the participants to identify DDIs and select an appropriate management strategy was low. These results support the need for additional DDI education in this institution's health curricula.
AB - Background: It is essential that current and future health professionals be able to evaluate for possible clinically significant drug-drug interactions (DDIs) and when detected, determine appropriate management strategies to prevent patient harm. Objective: Assess the validity of a DDI knowledge assessment instrument in a health professional student population. Methods: This study recruited health professional students (medical, nurse practitioner, and pharmacy) beginning experiential training at the University of Arizona. Students were given a knowledge assessment instrument that included 15 medication pairings selected on the basis of clinical importance and were asked to select the most appropriate DDI management strategy for each pair by selecting " avoid combination," " usually avoid combination," " take precautions," or " no special precautions." Data were analyzed in 2 ways because of the subjective nature of classifying DDIs into specific management categories. In the first analysis, respondents were given credit for a correct item only if they selected the management strategy deemed appropriate (management strategy analysis). In another analysis, students were given credit for an item only if they correctly identified specific DDIs (DDI recognition analysis). Rasch analysis was used to assess the validity of the knowledge instrument. Results: A total of 165 of the 226 eligible health professional students completed the DDI knowledge assessment (73% response rate). The mean score for management strategy analysis was 3.82 out of 15, whereas DDI recognition analysis produced a higher average (mean. =6.55). Good reliability was demonstrated in both strategies, and no ceiling or floor effects were observed. Some construct underrepresentation occurred with both scoring strategies, and some mistargeting was identified when analyzing the management strategy. Conclusions: Although improvements in construct representation may be beneficial, the instrument used demonstrated good reliability and validity and could be used by educators to assess and improve DDI knowledge. The ability of the participants to identify DDIs and select an appropriate management strategy was low. These results support the need for additional DDI education in this institution's health curricula.
KW - Drug interaction
KW - Education
KW - Health professional student
KW - Rasch
UR - http://www.scopus.com/inward/record.url?scp=79952700768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952700768&partnerID=8YFLogxK
U2 - 10.1016/j.sapharm.2010.01.001
DO - 10.1016/j.sapharm.2010.01.001
M3 - Article
C2 - 21397878
AN - SCOPUS:79952700768
SN - 1551-7411
VL - 7
SP - 16
EP - 26
JO - Research in Social and Administrative Pharmacy
JF - Research in Social and Administrative Pharmacy
IS - 1
ER -